ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in November 2021. Updated November 30, 2021.
A roundup of FDA’s actions in November 2021.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in November 2021. Updated November 30, 2021.
A roundup of FDA’s actions in November 2021.